ASP Isotopes (NASDAQ:ASPI) Stock Price Up 7.4% – Should You Buy?

ASP Isotopes Inc. (NASDAQ:ASPI)’s share price was up 7.4% during trading on Tuesday . The stock traded as high as $9.07 and last traded at $8.88. Approximately 1,141,533 shares changed hands during trading, a decline of 20% from the average daily volume of 1,433,961 shares. The stock had previously closed at $8.27.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ASPI. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. HC Wainwright lowered their price target on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Canaccord Genuity Group started coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Stock Performance

The business has a 50 day simple moving average of $4.01 and a 200 day simple moving average of $3.59. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 2.06. The company has a market capitalization of $567.17 million, a PE ratio of -14.06 and a beta of 3.88.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million during the quarter. Equities research analysts predict that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Investors Weigh In On ASP Isotopes

Several large investors have recently bought and sold shares of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in shares of ASP Isotopes in the 3rd quarter valued at approximately $6,249,000. Telemark Asset Management LLC bought a new position in shares of ASP Isotopes during the third quarter valued at approximately $4,726,000. Vanguard Group Inc. lifted its position in ASP Isotopes by 479.1% in the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after purchasing an additional 844,705 shares during the period. GSA Capital Partners LLP raised its position in shares of ASP Isotopes by 96.0% during the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock worth $2,143,000 after purchasing an additional 377,721 shares during the period. Finally, Marshall Wace LLP grew its stake in ASP Isotopes by 389.6% in the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.